收益预期修正

Search documents
U.S. Steel (X) Surges 5.1%: Is This an Indication of Further Gains?
ZACKS· 2025-06-17 10:35
Group 1 - United States Steel (X) shares increased by 5.1% to close at $54.85, with a notable volume of shares traded, reflecting a 29.3% gain over the past four weeks [1][2] - The rally in U.S. Steel's shares followed President Trump's approval of its partnership with Nippon Steel, which included a National Security Agreement (NSA) involving approximately $11 billion in new investments by 2028 [2] - U.S. Steel is projected to report quarterly earnings of $0.41 per share, indicating a year-over-year decline of 51.2%, with expected revenues of $4.07 billion, down 1.1% from the previous year [3] Group 2 - The consensus EPS estimate for U.S. Steel has been revised 1.1% higher in the last 30 days, suggesting a potential for price appreciation [4] - U.S. Steel holds a Zacks Rank of 3 (Hold), indicating a neutral outlook within the Zacks Steel - Producers industry [5] - ArcelorMittal, another company in the same industry, closed 2.9% higher at $30.99, with a consensus EPS estimate of $1.11, reflecting a year-over-year increase of 76.2% [5][6]
Ibotta (IBTA) Surpasses Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-14 22:10
Company Performance - Ibotta reported quarterly earnings of $0.02 per share, exceeding the Zacks Consensus Estimate of $0.01 per share, compared to earnings of $0.54 per share a year ago, representing an earnings surprise of 100% [1] - The company posted revenues of $84.57 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.52%, and showing an increase from year-ago revenues of $82.33 million [2] - Over the last four quarters, Ibotta has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Outlook - Ibotta shares have declined approximately 23.2% since the beginning of the year, while the S&P 500 has gained 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $89.9 million, and for the current fiscal year, it is $1.20 on revenues of $384.6 million [7] - The estimate revisions trend for Ibotta is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Technology Services industry, to which Ibotta belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar?
ZACKS· 2025-04-30 10:35
Company Overview - Hims & Hers Health, Inc. (HIMS) shares increased by 23% to close at $35.04, with trading volume significantly higher than usual, contrasting with a 3.6% loss over the previous four weeks [1][2] Recent Developments - The surge in Hims & Hers Health's shares is linked to the announcement of a deal to sell Novo Nordisk's weight-loss drug, Wegovy, on its telehealth platform, allowing U.S. customers to access NovoCare Pharmacy through Hims & Hers for $599 per month [2] Financial Performance Expectations - The company is projected to report quarterly earnings of $0.14 per share, reflecting a year-over-year increase of 180%, with revenues expected to reach $537.85 million, a 93.4% rise from the same quarter last year [3] - The consensus EPS estimate for the upcoming quarter has been revised 21.3% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Industry Context - Hims & Hers Health is categorized within the Zacks Medical Info Systems industry, where Health Catalyst (HCAT) is another player, having closed 0.3% higher at $4.07 but showing a -10.4% return over the past month [4]
Old National Bancorp (ONB) Moves 9.8% Higher: Will This Strength Last?
ZACKS· 2025-04-10 14:00
Old National Bancorp (ONB) shares ended the last trading session 9.8% higher at $19.70. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.8% loss over the past four weeks.Old National Bancorp stock surged, driven by a massive jump in the broad markets. The jump was fueled by President Donald Trump’s announcement of a 90-day tariff pause for the non-retaliating nations. This cheered the investors, driving the ONB s ...